BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17875368)

  • 1. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.
    McCarty D; Fuller B; Kaskutas LA; Wendt WW; Nunes EV; Miller M; Forman R; Magruder KM; Arfken C; Copersino M; Floyd A; Sindelar J; Edmundson E
    Drug Alcohol Depend; 2008 Jan; 92(1-3):200-7. PubMed ID: 17875368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problems.
    Palepu A; Cheng DM; Kim T; Nunes D; Vidaver J; Alperen J; Saitz R; Samet JH
    J Subst Abuse Treat; 2006 Dec; 31(4):411-7. PubMed ID: 17084795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health services for women in outpatient substance abuse treatment.
    Campbell CI; Alexander JA
    Health Serv Res; 2005 Jun; 40(3):781-810. PubMed ID: 15960691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders.
    Grella CE; Stein JA
    Psychiatr Serv; 2006 Jul; 57(7):1007-15. PubMed ID: 16816286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions.
    Kipnis SS; Herron A; Perez J; Joseph H
    Mt Sinai J Med; 2001 Jan; 68(1):28-32. PubMed ID: 11135503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which substance abuse treatment facilities offer dual diagnosis programs?
    Mojtabai R
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):525-36. PubMed ID: 15540491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organizational determinants of outpatient substance abuse treatment duration in women.
    Campbell CI; Alexander JA; Lemak CH
    J Subst Abuse Treat; 2009 Jul; 37(1):64-72. PubMed ID: 19038526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results.
    Gossop M; Marsden J; Stewart D; Kidd T
    Addiction; 2003 Mar; 98(3):291-303. PubMed ID: 12603229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-user treatment programs in a large metropolitan area.
    Polinsky ML; Hser YI; Anglin MD; Maglione MA
    Subst Use Misuse; 1998 Jun; 33(8):1735-61. PubMed ID: 9680091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The substance abuse counseling workforce: education, preparation, and certification.
    Rieckmann T; Farentinos C; Tillotson CJ; Kocarnik J; McCarty D
    Subst Abus; 2011 Oct; 32(4):180-90. PubMed ID: 22014248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study.
    Wu LT; Pan JJ; Blazer DG; Tai B; Stitzer ML; Woody GE
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S70-9. PubMed ID: 20307798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An organizational analysis of service patterns in outpatient drug abuse treatment units.
    D'Aunno T; Vaughn TE
    J Subst Abuse; 1995; 7(1):27-42. PubMed ID: 7655310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.
    Friedmann PD; Lemon SC; Stein MD; D'Aunno TA
    Health Serv Res; 2003 Jun; 38(3):887-903. PubMed ID: 12822917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A county survey of mental health services in drug treatment programs.
    Grella CE; Hser YI
    Psychiatr Serv; 1997 Jul; 48(7):950-2. PubMed ID: 9219307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs.
    McCarty D; Fuller BE; Arfken C; Miller M; Nunes EV; Edmundson E; Copersino M; Floyd A; Forman R; Laws R; Magruder KM; Oyama M; Prather K; Sindelar J; Wendt WW
    Psychiatr Serv; 2007 Feb; 58(2):181-90. PubMed ID: 17287373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in acute mental health care: comparing psychiatric and substance abuse treatment programs.
    Timko C; Lesar M; Calvi NJ; Moos RH
    J Behav Health Serv Res; 2003; 30(2):145-60. PubMed ID: 12710369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.
    Rosa C; Campbell A; Kleppinger C; Sampson R; Tyson C; Mamay-Gentilin S
    Clin Trials; 2009 Apr; 6(2):151-61. PubMed ID: 19342468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.